Zapała, P.; Garbas, K.; Lewandowski, Z.; Zapała, Ł.; Ślusarczyk, A.; Ślusarczyk, C.; Mielczarek, Ł.; Radziszewski, P.
The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study. Cancers 2022, 14, 4135.
https://doi.org/10.3390/cancers14174135
AMA Style
Zapała P, Garbas K, Lewandowski Z, Zapała Ł, Ślusarczyk A, Ślusarczyk C, Mielczarek Ł, Radziszewski P.
The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study. Cancers. 2022; 14(17):4135.
https://doi.org/10.3390/cancers14174135
Chicago/Turabian Style
Zapała, Piotr, Karolina Garbas, Zbigniew Lewandowski, Łukasz Zapała, Aleksander Ślusarczyk, Cezary Ślusarczyk, Łukasz Mielczarek, and Piotr Radziszewski.
2022. "The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study" Cancers 14, no. 17: 4135.
https://doi.org/10.3390/cancers14174135
APA Style
Zapała, P., Garbas, K., Lewandowski, Z., Zapała, Ł., Ślusarczyk, A., Ślusarczyk, C., Mielczarek, Ł., & Radziszewski, P.
(2022). The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study. Cancers, 14(17), 4135.
https://doi.org/10.3390/cancers14174135